These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68 related articles for article (PubMed ID: 4380769)
41. Antibody response of guinea pigs and white mice to nucleoprotein component of influenza virus as studied by gel double diffusion. Styk B; Hána L Acta Virol; 1968 May; 12(3):203-7. PubMed ID: 4385149 [No Abstract] [Full Text] [Related]
42. [The use of diploid cell cultures in the study of the effect of chemical compounds on the influenza viruses]. Tolstova TI; Bogdanova NS; Pershin GN Farmakol Toksikol; 1967; 30(1):82-7. PubMed ID: 4969870 [No Abstract] [Full Text] [Related]
44. Concerning the nature of the viral neutralizing activity of bovine serum. Ackermann WW; Dinka S Acta Virol; 1965 Nov; 9(6):526-33. PubMed ID: 4379436 [No Abstract] [Full Text] [Related]
45. Isolation and antiviral activity of the hymnemic acids. Sinsheimer JE; Rao GS; McIlhenny HM; Smith RV; Maassab HF; Cochran KW Experientia; 1968 Mar; 24(3):302-3. PubMed ID: 5661439 [No Abstract] [Full Text] [Related]
46. Influenza virus inhibitor secretion in the colostrum of postmature Chinese women. Shortridge KF; Wong R J Trop Med Hyg; 1976 Apr; 79(4):92. PubMed ID: 933227 [No Abstract] [Full Text] [Related]
47. Human MN glycoproteins: dependence of blood-group and anti-influenza virus activities on their molecular size. Springer GF Biochem Biophys Res Commun; 1967 Aug; 28(4):510-3. PubMed ID: 6052485 [No Abstract] [Full Text] [Related]
48. Studies on antiviral immunity using tissue culture methods. I. The susceptibility and resistance of lung tissue explants to influenza virus in previously immunised animals. SOLOVYOV VD; ALEKSEYEVA AK Acta Virol; 1960 May; 4():129-36. PubMed ID: 13854897 [No Abstract] [Full Text] [Related]
49. [Use of the principle of immunochromatography for the production of highly purified serum inhibitors of influenza virus]. Poliak RIa; Smorodintsev AA Vopr Virusol; 1968; 13(1):51-6. PubMed ID: 5686852 [No Abstract] [Full Text] [Related]
50. Purification and some properties of the thermostable inhibitor against avid A2 influenza virus from horse serum. KRIZANOVA-LAUCIKOVA O; SZANTO J; KOCISKOVA D Acta Virol; 1961 Jan; 5():4-11. PubMed ID: 13831079 [No Abstract] [Full Text] [Related]
51. Serum inhibitors of myxoviruses. Krizanová O; Rathová V Curr Top Microbiol Immunol; 1969; 47():125-51. PubMed ID: 4305308 [No Abstract] [Full Text] [Related]
53. Sensitivity of A2-Hong Kong and pre-1968 A2 influenza virus strains to normal serum inhibitors. de Sousa CP; Bal A Acta Virol; 1971 Sep; 15(5):367-73. PubMed ID: 4399134 [No Abstract] [Full Text] [Related]
54. Natural and synthetic sialic acid-containing inhibitors of influenza virus receptor binding. Matrosovich M; Klenk HD Rev Med Virol; 2003; 13(2):85-97. PubMed ID: 12627392 [TBL] [Abstract][Full Text] [Related]
55. Purification of bovine serum beta-inhibitor by chromatographic methods and its reaction with A1 influenza virus. Krizanová O; Sokol F Acta Virol; 1966 Jan; 10(1):35-42. PubMed ID: 4380769 [No Abstract] [Full Text] [Related]
56. Purification and properties of an influenza virus inhibitor isolated from mouse lungs. Lobodzińska M; Krizanová O Acta Virol; 1966 Jan; 10(1):28-34. PubMed ID: 4380768 [No Abstract] [Full Text] [Related]